Search results

Filter

Filetype

Your search for "*" yielded 565769 hits

Tabita Rosendal was interviewed for France 24 about Panama’s decision to revoke CK Hutchison’s port concessions in Balboa and Cristobal

Panama's decision exemplifies increasing pressure exerted by the US on Latin American countries, and could spell trouble for Beijing's strategic interests in the region Last week, Tabita Rosendal spoke with France 24 about Panama’s decision to revoke CK Hutchison’s port concessions in Balboa and Cristobal. She explained that the move reflects growing pressure from the Trump administration and fits

https://www.ace.lu.se/article/tabita-rosendal-was-interviewed-france-24-about-panamas-decision-revoke-ck-hutchisons-port - 2026-07-05

Going Plant-forward in China

Our PhD candidate Gina Song Lopez has recently published her article titled “Going Plant-Forward? Dietary Publics and Plant-Based Lifestyle Advocacy in Contemporary China” in Asian Studies Review. The article discusses China’s growing vegan, vegetarian, and flexitarian ‘dietary publics’ across online and offline foodscapes. The study combines digital food studies with onsite fieldwork, and foregro

https://www.ace.lu.se/article/going-plant-forward-china - 2026-07-05

Tabita Rosendal has published a new open-access book chapter on the Buddhist diplomacy of former Sri Lankan President Ranil Wickremesinghe

Ranil Wickremesinghe, who was President of Sri Lanka from 2022 to 2024, utilized Buddhist diplomacy to ensure his political legitimacy and longevity - similarly to other Sri Lankan leaders of state Tabita Rosendal has published a new open‑access book chapter in Figures of Buddhist Diplomacy in Modern Asia, edited by Jack Meng‑Tat Chia, examining Ranil Wickremesinghe’s use of Buddhist diplomacy. Th

https://www.ace.lu.se/article/tabita-rosendal-has-published-new-open-access-book-chapter-buddhist-diplomacy-former-sri-lankan - 2026-07-05

The Centre’s outreach program to Myanmar students impacted by conflict and displacement highlighted in Nature magazine

Researcher Dr. Elizabeth Rhoads was recently interviewed in Nature about her work with Myanmar students and educational providers in displacement. The Pilot Capstone Project led by Lund University and housed at the Centre for East and South-East Asian Studies is an international consortium including University of Toronto, Northern Illinois University, University of Montana, and Palacky University

https://www.ace.lu.se/article/centres-outreach-program-myanmar-students-impacted-conflict-and-displacement-highlighted-nature - 2026-07-05

Gina (Chih-Lan) Song Lopez has received her doctorate degree

On Monday, 23 March, Gina (Chih-Lan) Song Lopez successfully defended her dissertation "Foodscapes of Civil Society: Veg*n advocacy and sustainability transitions in the Sino-cultural sphere" This dissertation is about social change ‘and’, ‘with’, as well as ‘through’ food. It examines the rise and expansion of novel approaches to veganism and plant-based lifestyles in the Sino-cultural sphere by

https://www.ace.lu.se/article/gina-chih-lan-song-lopez-has-received-her-doctorate-degree - 2026-07-05

Assistant Professor in Southeast Asian Studies specialising in Governance, Justice, and Sustainable Futures

Lund University is recruiting an Assistant Professor (Associate Senior Lecturer) within the Lund University Programme for Global Excellence. The position will be placed within one of five sustainability themes in the humanities or theology. One of the themes is Governance, Justice and Sustainable Futures (PDF, new tab), placed at the Centre for East and South-East Asian Studies.The application dea

https://www.ace.lu.se/article/assistant-professor-southeast-asian-studies-specialising-governance-justice-and-sustainable-futures - 2026-07-05

New open-access article on technocracy in Cambodian politics

In a new Critical Asian Studies article, Kimhean Hok uncovers reform patterns that have significantly strengthened Cambodia’s administrative state while reinforcing authoritarian rule. In the article, Kimhean Hok argues that Cambodia should no longer be understood simply as a system with a strong ruling party and a weak state. Instead, he shows that the country has undergone what he calls a “techn

https://www.ace.lu.se/article/new-open-access-article-technocracy-cambodian-politics - 2026-07-05

Is OA linked to cancer?

In a new Swedish study by Lund University on comorbidities in osteoarthritis, researchers studied if people with osteoarthritis are at an increased risk for cancer compared to people without osteoarthritis. The study focused on the four most common cancer types, lung, colon, breast, and prostate cancer. Researchers found no differences in the risk of being diagnosed with colon cancer if you had os

https://www.arthritisportal.lu.se/article/oa-linked-cancer - 2026-07-05

Your genes play a part in the development of OA and perceived joint pain

Previous studies from Iceland have shown how osteoarthritis is often inherited and can be traced back several generations. A gene (genetic predisposition) is a segment of DNA containing hereditary information and is inherited from our biological parents. A new international study published in the high-ranking scientific journal Cell has discovered that a large number of genes are associated with o

https://www.arthritisportal.lu.se/article/your-genes-play-part-development-oa-and-perceived-joint-pain - 2026-07-05

Devil's Claw - the herbal medicine with a continued uncertain effect on OA pain

Devil's Claw (Harpagophytum procumbens) is a plant in the sesame family native South Africa that has long been used as a herbal medicine to treat a number of different diseases. The plant is believed to be able to reduce joint pain and joint stiffness as it is said to have analgesic and anti-inflammatory properties. However, the actual properties of devil's claw are yet not fully understood. There

https://www.arthritisportal.lu.se/article/devils-claw-herbal-medicine-continued-uncertain-effect-oa-pain - 2026-07-05

The global burden of osteoarthritis

Osteoarthritis has been described as the 15th most common cause of so-called “years lived with disability” (YLDs) in the world, which is a measure used to shed light on the burden of various diseases on society. According to the researchers, the economic costs caused by the disease correspond to about 1-2.5% of the gross domestic product (GDP) in most countries. A new article from a group of Ameri

https://www.arthritisportal.lu.se/article/global-burden-osteoarthritis - 2026-07-05

Common comorbidities in osteoarthritis

In a new Swedish study by Lund University, researchers looked at how common it is with comorbidities in osteoarthritis of the knee and/or hip. The study was published in the American journal Arthritis Care & Research. The study analyzed data collected from the province of Scania's population between the years 1998 and 2017. Newly diagnosed osteoarthritis patients were at a slightly higher risk of

https://www.arthritisportal.lu.se/article/common-comorbidities-osteoarthritis - 2026-07-05

The effect of PRP on ankle OA: No better than placebo

Earlier in October, we reported on a research study that showed that platelet-rich plasma (PRP) injections for treating osteoarthritis of the knee did not have a better effect on OA symptoms than placebo. Last week, results from a new study on PRP were published. The researchers concluded that PRP injections had no effect on ankle OA compared to placebo. The Dutch study included 100 ankle OA patie

https://www.arthritisportal.lu.se/article/effect-prp-ankle-oa-no-better-placebo - 2026-07-05

Not approved in the EU: Another setback for the drug tanezumab

The painkiller tanezumab was not approved by the European Medicine's Agency. At the beginning of 2021, news came that tanezumab, a new pain medication, would be launched in the US and Europe.  However, in March, tanezumab suffered a setback in the United States when the US Food and Drug Administration rejected the drug for osteoarthritis pain. There was continued uncertainty about the launch of th

https://www.arthritisportal.lu.se/article/not-approved-eu-another-setback-drug-tanezumab - 2026-07-05

The many risks of the painkiller tramadol

Tramadol is an increasingly common drug prescribed for pain. Tramadol is a synthetic opioid (manufactured in a lab) that differs somewhat in its chemical structure compared to the natural opioid codeine. Other opioids include morphine and heroin. All opioids have analgesic properties and are extremely addictive. In a new study based on primary care data from Spain, the risks of a number of side ef

https://www.arthritisportal.lu.se/article/many-risks-painkiller-tramadol - 2026-07-05

The benefits and side effects of common pain meds for osteoarthritis of the knee and hip

In a new meta-analysis (a compilation of results from a number of different research studies), the benefits and side effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), paracetamol, and opioids have been studied. The research study included data from 181 publications describing 192 clinical trials involving a total of over 100,000 patients. The researchers found that the NSAID etoricoxib (6

https://www.arthritisportal.lu.se/article/benefits-and-side-effects-common-pain-meds-osteoarthritis-knee-and-hip - 2026-07-05

How common is knee osteoarthritis?

A Chinese research group has compiled data from 88 different scientific studies on the prevalence of knee osteoarthritis. The studies were from all around the world and together included more than 10 million people. The researchers estimated that for individuals aged 40 years and older, the global prevalence of knee osteoarthritis is around 23%. This means that almost every fourth person over the

https://www.arthritisportal.lu.se/article/how-common-knee-osteoarthritis - 2026-07-05

PRP injections no more effective than placebo

PRP treatment (platelet-rich plasma) is a relatively new experimental treatment that is often marketed to be effective for patients with osteoarthritis. However, there is a lack of high-quality research claiming the effectiveness of the treatment. Researchers from Brazil have recently published results from a small clinical trial (including 61 patients) evaluating three different treatments. The p

https://www.arthritisportal.lu.se/article/prp-injections-no-more-effective-placebo - 2026-07-05

Osteoarthritis roundtable: Best from the ACR conference 2021

Doctors Jack Cush, Martin Englund, Gillian Hawker, Tihuna Neogi, and Kent Kwoh discuss the best OA research from the 2021 ACR (American College of Rheumatology) conference, including a new study indicating that the diabetes medicine metformin lowers the risk of developing osteoarthritis. Dr. Jack Cush is a professor of internal medicine at The University of Texas Southwestern Medical School, in th

https://www.arthritisportal.lu.se/article/osteoarthritis-roundtable-best-acr-conference-2021 - 2026-07-05

Increased burden by osteoarthritis in the world

In a recent study, a group of scientists have evaluated the burden of osteoarthritis over the past three decades, using data from the worldwide initiative ”Global Burden of Disease study 2019.  The results show that the number of people affected by osteoarthritis has increased by about 113 percent in 30 years, from about 248 million in year 1990 to about 530 million in year 2019. The authors concl

https://www.arthritisportal.lu.se/article/increased-burden-osteoarthritis-world - 2026-07-05